2014 UCL Business Award
The UCL Business Award seeks to mark the achievements of UCL academics who have delivered notable commercial projects. Previous award winner (2013), Professor Pete Coffey was selected in recognition for his efforts with the London Project - a research programme that aims to develop a cell therapy for Age-related Macular Degeneration (AMD). It is hoped that this will prevent blindness, restore sight and improve sufferers’ quality of life. In particular, the award recognised the work secured with Pfizer to develop treatments for AMD.
UCL Business PLC (UCLB) is a leading technology transfer company, which supports and commercialises research and innovations arising from UCL, one of the UK's leading research-led universities.
UCLB has a successful track record and strong reputation for identifying and protecting promising new technologies and innovations from UCL academics. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from the laboratory to be market ready. UCLB supports UCL’s Grand Challenges of increasing UCL’s positive impact on and contribution to Global Health, Sustainable Cities, Intercultural Interaction and Human Wellbeing.
UCL Business is pleased to continue the realisation of research through its work and by recognising projects which have done so through the 2014 UCL Business Award.